Evaluating the Risks of Clinical Research

被引:67
|
作者
Rid, Annette [1 ,2 ]
Emanuel, Ezekiel J. [1 ]
Wendler, David [1 ]
机构
[1] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA
[2] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland
来源
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
PERCUTANEOUS LIVER-BIOPSY; HEALTH UTILITIES INDEX; QUALITY-OF-LIFE; PEDIATRIC RESEARCH; OPTIMAL NUMBER; MINIMAL RISK; IMMUNOTHERAPY; COMPLICATIONS; BENEFIT; ETHICS;
D O I
10.1001/jama.2010.1414
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ethical appropriateness of clinical research depends on protecting participants from excessive risks. Yet no systematic framework has been developed to assess research risks, and as a result, investigators, funders, and review boards rely only on their intuitive judgments. Because intuitive judgments of risk are subject to well-documented cognitive biases, this approach raises concern that research participants are not being adequately protected. To address this situation, we delineate a method called the systematic evaluation of research risks (SERR), which evaluates the risks of research interventions by comparing these interventions with the risks of comparator activities that have been deemed acceptable. This method involves a 4-step process: (1) identify the potential harms posed by the proposed research intervention; (2) categorize the magnitude of the potential harms into 1 of 7 harm levels on a harm scale; (3) quantify or estimate the likelihood of each potential harm; and (4) compare the likelihood of each potential harm from the research intervention with the likelihood of harms of the same magnitude occurring as a result of an appropriate comparator activity. By explicitly delineating, quantifying, and comparing the risks of research interventions with the risks posed by appropriate comparator activities, SERR offers a way to minimize the influence of cognitive biases on the evaluation of research risks and thereby better protect research participants from excessive risks. JAMA. 2010; 304(13): 1472-1479
引用
收藏
页码:1472 / 1479
页数:8
相关论文
共 50 条
  • [1] Evaluating the Risks of Clinical Research: Direct Comparative Analysis
    Rid, Annette
    Abdoler, Emily
    Roberson-Nay, Roxann
    Pine, Daniel S.
    Wendler, David
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (07) : 390 - 398
  • [2] Evaluating the Risks of Clinical Research (vol 304, pg 1472, 2010)
    Rid, Annette
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (22): : 2484 - 2484
  • [3] Evaluating Appraisers' Research: uncertainties and risks
    Miccoli, Saverio
    Finucci, Fabrizio
    Murro, Rocco
    [J]. AESTIMUM, 2012, : 383 - 396
  • [4] Evaluating fever in infants: Judging the risks - clinical commentary
    Ward, R
    [J]. JOURNAL OF FAMILY PRACTICE, 2003, 52 (10): : 808 - 808
  • [5] Accounting for Competing Risks in Clinical Research
    Austin, Peter C.
    Ibrahim, Maria
    Putter, Hein
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (24): : 2125 - 2126
  • [6] Evaluating the Landscape of Clinical Research in Neurosurgery
    Wilde, Herschel W.
    Reese, Jared C.
    Azab, Mohammed A.
    Karsy, Michael
    Guan, Jian
    Rolston, John D.
    [J]. NEUROSURGERY, 2019, 85 (03) : E485 - E492
  • [7] Understanding and Evaluating Veterinary Clinical Research
    Buhles, William
    Kass, Philip H.
    [J]. JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2012, 48 (05) : 285 - 298
  • [8] EVALUATING THE RISKS
    SESODY, JJ
    [J]. CHEMICAL ENGINEERING, 1993, 100 (07) : 8 - 8
  • [9] Risks of Clinical Research Must Be Reasonable and Necessary
    Miller, D. Gibbes
    Kim, Scott Y. H.
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2017, 17 (10): : 79 - 81
  • [10] Clinical research and the financial markets: opportunities and risks
    Peter T Scardino
    [J]. Nature Clinical Practice Urology, 2005, 2 : 573 - 573